These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7533087)

  • 1. Role of CD44 cytoplasmic domain in hyaluronan binding.
    Perschl A; Lesley J; English N; Trowbridge I; Hyman R
    Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding.
    Lesley J; English N; Charles C; Hyman R
    Eur J Immunol; 2000 Jan; 30(1):245-53. PubMed ID: 10602047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
    Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
    J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism.
    Uff CR; Neame SJ; Isacke CM
    Eur J Immunol; 1995 Jul; 25(7):1883-7. PubMed ID: 7542594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody.
    Lesley J; Kincade PW; Hyman R
    Eur J Immunol; 1993 Aug; 23(8):1902-9. PubMed ID: 7688309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
    Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
    J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells.
    Asplund T; Heldin P
    Cancer Res; 1994 Aug; 54(16):4516-23. PubMed ID: 7519123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel heparin binding domain in RHAMM and evidence that it modifies HA mediated locomotion of ras-transformed cells.
    Yang B; Hall CL; Yang BL; Savani RC; Turley EA
    J Cell Biochem; 1994 Dec; 56(4):455-68. PubMed ID: 7534313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.
    Liao HX; Lee DM; Levesque MC; Haynes BF
    J Immunol; 1995 Oct; 155(8):3938-45. PubMed ID: 7561101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.
    Hathcock KS; Hirano H; Murakami S; Hodes RJ
    J Immunol; 1993 Dec; 151(12):6712-22. PubMed ID: 7505013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain.
    Liu D; Zhang D; Mori H; Sy MS
    Cell Immunol; 1996 Nov; 174(1):73-83. PubMed ID: 8929456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells.
    Lesley J; Hyman R
    Eur J Immunol; 1992 Oct; 22(10):2719-23. PubMed ID: 1382996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.
    Galandrini R; Galluzzo E; Albi N; Grossi CE; Velardi A
    J Immunol; 1994 Jul; 153(1):21-31. PubMed ID: 7515923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
    English NM; Lesley JF; Hyman R
    Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth.
    Katoh S; McCarthy JB; Kincade PW
    J Immunol; 1994 Oct; 153(8):3440-9. PubMed ID: 7523494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential.
    Culty M; Shizari M; Thompson EW; Underhill CB
    J Cell Physiol; 1994 Aug; 160(2):275-86. PubMed ID: 7518822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines.
    Teder P; Bergh J; Heldin P
    Cancer Res; 1995 Sep; 55(17):3908-14. PubMed ID: 7543820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two regions in the cytoplasmic domain of CD44 through which PMA, calcium, and foskolin differentially regulate the binding of CD44 to hyaluronic acid.
    Liu D; Liu T; Sy MS
    Cell Immunol; 1998 Dec; 190(2):132-40. PubMed ID: 9878114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.
    Lokeshwar VB; Fregien N; Bourguignon LY
    J Cell Biol; 1994 Aug; 126(4):1099-109. PubMed ID: 7519619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.